Cartesian Therapeutics
RNAC
#6869
Rank
A$0.70 B
Marketcap
$27.63
Share price
-5.09%
Change (1 day)
-48.42%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.48

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.49. In 2021 the company made an earnings per share (EPS) of -$0.37 an increase over its 2020 EPS that were of -$1.06.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.48
2021-$0.37-65.22%
2020-$1.06-43.44%
2019-$1.88-58.08%
2018-$4.49-9.35%
2017-$4.95-29.16%
2016-$6.99